BSEResult13 Aug 2026 · 13 Aug 2026, 02:09 pm

Financial Results pursuant to Regulation 33 of the SEBI (LODR) Reg, 2015

Desh Rakshak Aushdhalaya Ltd · 531521

✦ AI SummaryResults

Desh Rakshak Aushdhalaya Ltd has submitted its unaudited financial results for the quarter and year to date ended 30th June, 2026, as per Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company's revenue from operations for the quarter ended 30th June, 2026, was Rs. 82.83 lakhs, with a total revenue of Rs. 346.38 lakhs. The company's profit before exceptional and extraordinary items and tax for the quarter ended 30th June, 2026, was Rs. 8.03 lakhs.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Desh Rakshak Aushdhalaya Ltd - 531521 - Submission Of Quarterly And Year To Date Unaudited Financial Results For The Quarter Ended 30Th June, 2026 As Per Regulation 33 Of The SEBI (Listing Obligations And Disclosure Requirements), Regulations, 2015

Attachments (1)

📄

4fafb3e5-92e1-4118-9a48-7dbb9d6b9ec3.pdf

pdf

Download →
View document text
Established in 1901 CIN L33119UR1981PLC006092 DESH RAKSHAK AUSHDHALAYA LIMITED BHAGWANT KUTI KANKHAL-249408, HARIDWAR (UTTARAKHAND) INDIA Manufacturers of Ayurvedic and Herbal Product Phone: (01334) 243833, 245877, 242333 Tele Fax: (01334) 245866 E-mail: dral95@yahoo.com, dral96@yahoo.in website: www.deshrakshak.in To, Date: 13.08.2026 Corporate Compliance Department BSE Limited Phiroze Jeejeebhoy Towers Dalal Street Mumbai- 400001 BSE Scrip Code: 531521 Sub- Submission of Quarterly and Year to date Unaudited Financial Results for the quarter ended 30th June, 2026 as per Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015. Respected Sir/Mam, Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 mentioned in the captioned subject, the company Desh Rakshak Aushdhalaya Limited (“the Company”) (CIN: L33119UR1981PLC006092) are enclosing herewith Financial Results for the quarter and year to date ended 30th June, 2026 which already approved by the Board of Directors of the Company at the Meeting held on Thursday, August 13, 2026, Limited Review Report on the Financial Results for the quarter and year to date ended June 30, 2026 and Declaration on unmodified opinion in respect of the Limited Review Report. You are requested to take on the record and do the needful. Thanking You, Yours Faithfully For Desh RakshakAushdhalaya Limited Tosh Kumar Jain (Managing Director) DIN: 01540363 Date: 13.08.2026 Place: Haridwar J"'" ANIL & Co. 10, Guru Mandai Ashram CHARTEREDACCOUNTANTS Devpura,HARIDWAR-249401 Phone: 9837072210 IndependentAuditor's Limited Review Report on Standalone Unaudited Quarterly/Half YearlyNearto dateFinancialResultsof the DeshRakshakAushdhalayaLimited pursuant to the Regulation33of the Securities and ExchangeBoard of India (Listing Obligations andDisclosureRequirements)Regulations.2015(asamended). Reviewreportto TheBoardof Directors, DeshRakshakAushdhalayaLimited BhagwantKuti Kankhal,Haridwar,Uttarakhand-249408India We have reviewed the accompanying statement of Unauditedfinancial results ("theStatement")of DeshRakshakAushdhalayaLimitedfor theQuarterandthreeMonths endedJune 30,2026,being submitted by the company pursuant to the requirementsof Regulation33of the Securitiesand ExchangeBoardof India("SEBI") (Listing Obligations and Disclosure Requirements) Regulations, 2015 (as amended) including relevant circulars issued bythe SEBIfrom time to time.This statementis the responsibility of the Company's Management and has been approved by the Board of Directors. Our responsibilityisto issueareportonthesefinancial statementsbasedonour review. We conducted our review of the Statement in accordance with the Standard on ReviewEngagements (SRE) 2410 "Review of Interim Financial Information Performed by the Independent Auditor of the Entity", issued by the lnstitute of Chartered Accountantsof India.Thisstandardrequiresthatweplanandperformthe reviewto obtain moderate assurance as to whether the financial statements are free of material misstatement. A review is limited primarily to inquiries of company personnel and analyticalproceduresappliedto financial dataand thus provides less assurance than an audit. Wehavenot performedanaudit andaccordingly, we do not expressanaudit opiniolJ: Basedon our reviewconducted asabove,nothing hascometo our attention that causes usto believethat the accompanyingstatementof Unauditedfinancial results preparedin accordance with applicable accounting standards and other recognized accounting practicesandpolicies hasnotdisclosedthe information requiredto bedisclosed interms of Regulation33of the Securities and ExchangeBoardof India(Listing Obligations and DisclosureRequirements)Regulations,2015,asamended,including the mannerin which it isto bedisclosed,orthat itcontainsanymaterialmisstatement. OurconclusionontheStatementis notmodifiedinrespectoftheabovematter. FOR AND ON BEHALF OF MIS ANIL JAIN & CO. CHARTERED ACCOU NTANTS PLACE: HARIDWAR DATED: 13.08.2026 Desh Rakshak Aushdhalaya Limited CIN:L33119UR1981PLC006092 R/o: Bhagwant Kuti Kankhal, Haridwar, Utttarakhand- 249408 India Email Id: dral96@yahoo.in; Website: www.deshrakshak.in STATEMENT OF STANDALONE UNAUDITED FINANCIAL RESULTS FOR THE QUARTER AND YEAR TO DATE ENDED 30TH JUNE, 2026 (Rupees in Lakhs Except Earning Per Equity Share and Face Value Per Equity Share) Particulars Quarter Ended (3 Months Ended) Year Ended 30-Jun-2026 31-Mar-2026 30-Jun-2025 31-Mar-2026 31-Mar-2025 (Refer Notes Below) Un Audited Audited UnAudited Audited Audited I. Revenue from operations 82.83 345.33 129.99 710.44 627.06 II. Other Income 0.00 1.05 0.00 1.05 3.32 III. Total Revenue (I)+(II) 82.83 346.38 129.99 711.49 630.38 IV. Expenses Cost of Materials consumed 8.22 180.91 50.33 298.33 256.77 Purchase of stock in trade 0.00 0.00 0.00 0.00 0.00 Changes in inventories of raw material, work-in-progress and 0.00 0.00 0.00 0.00 0.00 finished goods-in-trade Employees benefits expense 22.89 26.81 26.04 103.12 96.62 Finance Cost 5.40 9.61 5.41 28.40 29.81 Depreciation and amortisation expense 10.91 12.80 10.04 43.64 41.60 Other expenses 27.38 75.45 28.58 170.48 149.11 Total Expenses 74.80 305.58 120.40 643.97 573.91 V. Profit/(Loss) before exceptional and extraordinary items and tax 8.03 40.80 9.59 67.52 56.47 (III- IV) VI. Exceptional items 0.00 0.00 0.00 0.00 0.00 VII. Profit/(Loss) before extraordinary items and tax (V-VI) 8.03 40.80 9.59 67.52 56.47 VIII. Extraordinary items 0.00 0.00 0.00 0.00 0.00 IX. Profit and Losses before taxes ( VII- VIII) 8.03 40.80 9.59 67.52 56.47 X. Tax Expense (1) Current tax 0.00 11.30 0.00 11.30 8.81 (2) Deferred tax 0.00 0.00 0.00 0.00 0.00 XI. Net Profit/(Loss) for the period from continuing operations (IX- 8.03 29.50 9.59 56.22 47.66 XII. Profit/(Loss) from discontinuing operations 0.00 0.00 0.00 0.00 0.00 XIII. Tax expense of discontinuing operations 0.00 0.00 0.00 0.00 0.00 0.00 XIV. Profit/(Loss) from Discontinuing operations (after tax) (XII-XIII) 0.00 0.00 0.00 0.00 XV. Profit/(Loss) for the period (XI+XIV) 8.03 29.50 9.59 56.22 47.66 XVI. Other Comprehensive Income / (Expense) (OCI) A. (i) Items that will not be reclassified to Profit or loss 0.00 0.00 0.00 0.00 0.00 (ii) Income tax relating to items that will not be reclassified to 0.00 Profit or Loss 0.00 0.00 0.00 0.00 B. (i) Items that will be reclassified to Profit or loss 0.00 0.00 0.00 0.00 0.00 (ii) Income tax relating to items that will be reclassified to Profit or 0.00 Loss 0.00 0.00 0.00 0.00 0.00 Total Other Comprehensive Income / (Expense) (OCI) (A+ B) 0.00 0.00 0.00 0.00 8.03 56.22 Total Comprehensive Income/ (Expense) for the period (XV+XVI) 29.50 9.59 47.66 XVII. Paid-up equity share capital (Face Value of the share shall be 569.83 569.83 443.83 569.83 443.83 indicated) Face Value Per Equity Share 10.00 10.00 10.00 10.00 10.00 XVIII. Reserve excluding revaluation reserves as per balance sheet 523.61 475.94 of previous accounting year XIX. Earning Per Equity Share (a) Basic 0.14 0.52 0.22 0.99 1.07 (b) Diluted 0.14 0.52 0.22 0.99 1.07 Notes (1) The above results have been reviewed by the Audit Committee and taken on record by the Board of Directors at their Meeting held on 13th day of August, 2026. . (2) The above results have been reviewed by the Statutory Auditors of the Company. (3)Previous quarter/year figures have been restated wherever necessary to make them comparable. (4) Disclosure of segment wise information as per AS-17 is not applicable, as dealing with Ayurvedic Medicines is the company's only business Segments (5) In terms of Regulation 13(3) of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, there were no investor complaint pending at the beginning of the quarter or lying unresolved at 30-06-2026. (6) The members of the Company in the Extra-Ordinary General M [Showing first 8,000 characters — download PDF for full document]